Commentary Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/haematology.2.027
A Review of Testing Strategies for Bacterial Risk Control in Platelets Recommended by the FDA
Remo P. Vallejo1,*, Paul D. Mintz1
- 1Verax Biomedical Incorporated, Marlborough, MA, USA 01752
Corresponding Author
Remo P. Vallejo, yvallejo@veraxbiomedical.com
Received Date: March 29, 2021
Accepted Date: April 29, 2021
Vallejo RP, Mintz PD. A Review of Testing Strategies for Bacterial Risk Control in Platelets Recommended by the FDA. J Clin Haematol. 2021; 2(2): 40-47.
Copyright: © 2021 Vallejo RP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Lipoprotein Apheresis: First FDA Indicated Treatment for Elevated Lipoprotein(a)
Lipoprotein(a) [Lp(a)] is a genetically determined lowdensity lipoprotein (LDL) particle that is comprised of apolipoprotein(a) [apo(a)] and apolipoprotein B-100 (apoB) moieties. It is well-established that elevated Lp(a) is an independent risk factor for cardiovascular disease (CVD).
A Review of Testing Strategies for Bacterial Risk Control in Platelets Recommended by the FDA
Platelet transfusion is associated with the risk of sepsis from bacterial contamination due to the need to store units at room temperature in oxygen-permeable bags. This risk associated with platelet transfusion is highest among all transfusable blood components. Measures applied in the past several decades have significantly reduced the occurrence of patient morbidity and mortality but have not eliminated it totally. Sampling of processed platelets for bacterial culture after 24 hours post-collection lowered the rate of infection but still allowed contaminated transfusions to occur due to low levels of bacteria being missed during sampling. Bacteria entering log phase growth after 24 hours may not be detected.
Preventing Stroke in Sickle Cell Disease: 2021. The Role of Transcranial Doppler Ultrasound (TCD) When the Use of Transfusion is Problematic
While TCD is an indicator of risk, not a biopsy diagnosis (such as proof of cancer), at some point in the velocity spectrum the high velocity detected by TCD reaches what many believe is an unacceptable risk of stroke.
Novel Treatments Targeting the Dysregulated Cell Signaling Pathway during Sepsis
Previously characterized as a purely immune mediated disease, sepsis is now recognized as a dysregulated multisystem response against a pathogen. Recognition of the infectious agent by pathogen recognition receptors (PRRs) can initiate activation of the NF-κB signaling pathway and promote the secretion of proinflammatory cytokines. During sepsis, the activation of NF-κB is dysregulated and results in cytokine storm, or the pathologic release of cytokines.
Ethanol Consumption and Sepsis: Mechanisms of Organ Damage
Sepsis is highly prevalent, and is one of the main causes of mortality among hospitalized patients. Ethanol consumption in large quantities compromises the normal functioning of the body, leading to dysfunction of multiple different organ systems. The association between sepsis and ethanol is not fully understood, but it is well accepted that ethanol